http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105377247-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate | 2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105377247-B |
| titleOfInvention | Phosphatidylcholine-containing pharmaceutical preparation for the treatment of ulcerative colitis |
| abstract | A pharmaceutical formulation comprising a phosphatidylcholine product of formula (I), wherein R 1 is a residue of a saturated or unsaturated fatty acid having 12-24 carbon atoms, and R 2 is a residue of a saturated or unsaturated fatty acid having 12-24 carbon atoms, and wherein the phosphatidylcholine The product (PC) contains the following amounts of fatty acids: 55-72 linoleic acid, 10-18 palmitic acid, 07-15 oleic acid, 02-08 linolenic acid, 02-08 stearic acid, and at least one for delayed release as an excipient for the treatment of modified ulcerative colitis. |
| priorityDate | 2013-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.